Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
about
A Review of Quality Measures for Assessing the Impact of Antimicrobial Stewardship Programs in HospitalsSurveillance of antibiotic resistanceCommunity-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries.Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014.Antibiotic consumption and antibiotic stewardship in Swedish hospitals.Rapid identification of major Escherichia coli sequence types causing urinary tract and bloodstream infections.Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center.Mechanisms of antimicrobial resistance in Gram-negative bacilli.Comparison of Second- and Third-Generation Cephalosporin as Initial Therapy for Women with Community-Onset Uncomplicated Acute Pyelonephritis.Descriptive epidemiology of Escherichia coli bacteraemia in England, April 2012 to March 2014.The Role of Topical Antiseptic Agents Within Antimicrobial Stewardship Strategies for Prevention and Treatment of Surgical Site and Chronic Open Wound Infection.Are third-generation cephalosporins unavoidable for empirical therapy of community-acquired pneumonia in adult patients who require ICU admission? A retrospective studyA Risk Assessment of Antibiotic Pan-Drug-Resistance in the UK: Bayesian Analysis of an Expert Elicitation StudyDeveloping the first national antimicrobial prescribing and stewardship competences.Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department.The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae.Bacteremia in children: epidemiology, clinical diagnosis and antibiotic treatment.Antibiotic resistance: what, why, where, when and how?Sparing carbapenem usage.Correlation between antibiotic consumption and resistance of bloodstream bacteria in a University Hospital in North Eastern Italy, 2008-2014.In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.Population structure of Escherichia coli causing bacteraemia in the UK and Ireland between 2001 and 2010.Impact of antibiotic restriction on resistance levels of Escherichia coli: a controlled interrupted time series study of a hospital-wide antibiotic stewardship programme.Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales.Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae.Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis.Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years.Antibiotic consumption after implementation of a procalcitonin-guided antimicrobial stewardship programme in surgical patients admitted to an intensive care unit: a retrospective before-and-after analysis.Longitudinal trends and cross-sectional analysis of English national hospital antibacterial use over 5 years (2008-13): working towards hospital prescribing quality measures.
P2860
Q26749534-B6DA2B4B-B28F-4B30-98D1-17EC32A7DACBQ28082571-078E7E02-0D52-4707-95E3-87C356C6F486Q30358381-7CB297C1-4CE9-4991-A585-A089901F5A62Q31152845-3D5D8AF7-5083-4DF2-ACF0-EB88A457FCD8Q33667534-63E495E3-2003-4721-9855-F22EB6ED9D92Q34916386-5DEC2DCB-DE05-4943-AC2B-169EF903C4E0Q35147331-D1D5713B-913C-46A6-B9ED-D231C1A0F828Q35935319-DB6196D3-2B97-4D46-BAD2-B001A78A1B5AQ35971059-B3615698-825D-4B68-8086-A70F33A0969DQ37240953-47B381EC-DFC3-4197-8133-D308D9DCE1DBQ37618374-07159989-5C9F-4741-974B-27811B598F68Q37721755-1258D7CC-B04F-48B0-BF56-4FEEDFC5F8FFQ37729926-17564DA4-4E20-40B4-8BE9-35ABDF19875BQ38248478-7D3DF357-28CD-48F1-80B5-6C76F025BC7FQ38254769-D703A5C6-D6C2-446D-BF84-CC8257BF6B46Q38497797-F4BDB1D3-FF0D-48CF-B807-FD426A5B5927Q38542909-3E0549CC-0D6C-4847-B4A2-725998665F40Q38613665-CEBDB18F-E800-4EA3-9562-812CBCEC4621Q39388468-751B1FED-2862-4C09-8F8A-8C83CF636851Q40305798-193A58DF-C18D-4A4D-A70D-C0BD2C3DA5D9Q40363538-FEC02871-5B9B-4BBE-B0E9-92E0BCA25E8EQ40685741-683350FA-C745-4027-AD5B-EC81F1D7CAE8Q40724155-D741DC17-A4DF-4C78-882B-83FD1CC387F3Q40785739-495919C4-80ED-44D0-9423-4F6A1241405CQ41004466-109A6893-198F-4316-80F1-317BF90D8175Q41092239-8FBAB4AE-807D-4A86-96DD-99619A18FBB1Q41315930-4070E912-2E4C-47A6-AFFB-2D88AF50BA8BQ41544896-023E828C-EE51-47CF-9F36-239AACA2DAAAQ41705879-8833FB7C-87C6-479D-A6A3-3A2F80EE32AE
P2860
Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Declining cephalosporin and fl ...... : links to prescribing change?
@en
type
label
Declining cephalosporin and fl ...... : links to prescribing change?
@en
prefLabel
Declining cephalosporin and fl ...... : links to prescribing change?
@en
P2093
P356
P1476
Declining cephalosporin and fl ...... : links to prescribing change?
@en
P2093
Alan P Johnson
David M Livermore
Rosy Reynolds
Russell Hope
Ruth Blackburn
P304
P356
10.1093/JAC/DKT212
P407
P577
2013-06-13T00:00:00Z